How does the menstrual cycle affect epilepsy?
We are looking for females with epilepsy to be part of our study on how the menstrual cycle affects seizures in some women. If you have a menstrual cycle, we are including both those who do and do not experience a change in their seizures in the days surrounding when their period starts.
What's involved?
The study involves tracking your seizures and menstrual cycle for several months.
There are then 3 visits to the University of Auckland (Grafton) for an EEG, blood sample, and simple visual tests (2 hours each visit, 6 hours total).
You will be compensated $150 in vouchers (Countdown or Westfield) for your time and participation.
Eligibility criteria
- Female participants
- 14-45 years old
- Diagnosed with epilepsy
- Have one or more seizures during most months
- Do not currently use hormonal medication (except the Mirena or other IUD implant)
- Do not have polycystic ovary syndrome or very irregular periods
Contact details
Further information
For females that experience a change in their seizure around their period starting:
-
Participant Information Sheet - Catamenial Epilepsy (14-15 years old) . Size: 617.9 kB.
Document Description: For females that experience a change in their seizures around their period and are 14-15 years old.
-
Participant Information Sheet - Catamenial Epilepsy (16 years and up) . Size: 459.9 kB.
Document Description: For females that experience a change in their seizures around their period starting from 16 years and over.
For females that do not experience a change in their seizures around their period starting:
-
Participant Information Sheet - No Catamenial Epilepsy (14-15 years old) . Size: 498.1 kB.
Document Description: For females that DO NOT experience a change in their seizures around their period and are 14-15 years old.
-
Participant Information Sheet - No Catamenial Epilepsy (16 years and up). Size: 446.1 kB.
Document Description: For females that DO NOT experience a change in their seizures around their period at 16 years old and above.
This study is funded by The Neurological Foundation. Approved by the Central Health and Disability Ethics Committee (Reference Number: 21/CEN/201).